
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-362-3752
Dr. Al-Lozi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1988 - 1991
New York Medical College at St Michael's Medical CenterInternship, Internal Medicine, 1987 - 1988
King Edward Medical UniversityClass of 1980
Certifications & Licensure
IL State Medical License 1999 - 2029
MO State Medical License 1991 - 2027
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Myotonia: Recognition, Evaluation, and Differential Diagnosis.Jesse I Crayle, Muhammad Al-Lozi, Timothy M Miller
Muscle & Nerve. 2026-05-10 - 22 citationsSeptin-5 and -7-IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics.Shannon R Hinson, Josephe A Honorat, Ethan M Grund, Benjamin D Clarkson, Ramona Miske
Annals of Neurology. 2022-12-01 - 75 citationsPhase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.Richard Nowak, Christopher S. Coffey, Jonathan Goldstein, Mazen M. Dimachkie, Michael Benatar
Neurology. 2021-12-02
Press Mentions
Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus-Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy: The CHARTER StudyDecember 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









